Your browser doesn't support javascript.
loading
Advanced intraocular retinoblastoma: evolving criteria for group E disease.
Sedaghat, Ahad; Raval, Vishal; Jia, Renbing; Fan, Xianqun; Singh, Arun D.
Afiliación
  • Sedaghat A; Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, OH.
  • Raval V; Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.
  • Jia R; Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Fan X; Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Singh AD; Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, OH. Electronic address: SINGHA@ccf.org.
Can J Ophthalmol ; 2024 Apr 27.
Article en En | MEDLINE | ID: mdl-38688458
ABSTRACT
With evolving criteria for classifying intraocular retinoblastoma (RB) from International Intraocular Retinoblastoma Classification (IIRC, 2005) to International Classification of Retinoblastoma (ICRB, 2006), there have been changes in the inclusion criteria for groups E eyes that have not been widely recognized. This brief review highlights issues with the current classification systems (ICRB and IIRC) and layouts a theoretical framework arguing for merging of 2 existing classifications into 1 and subdividing the expanded group E RB, thereby preserving the possibility to reanalyze existing published data.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Can J Ophthalmol Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Can J Ophthalmol Año: 2024 Tipo del documento: Article
...